Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Log Out
EOLS
Stock Latest News
Ratings
Evolus: Strategic Developments and FDA Approvals Drive Buy Rating with Promising Growth Projections
5d ago
EOLS
Premium
Ratings
Evolus Gains ‘Buy’ Rating: FDA Approval and Unique Technology Drive Growth Potential
8d ago
EOLS
Premium
Ratings
Evolus Gains Buy Rating on Early FDA Approval and Strategic Market Positioning
8d ago
EOLS
Premium
Ratings
Evolus’s Strategic Advancements and Early FDA Approval Boost Growth Potential
9d ago
EOLS
Premium
The Fly
Evolus trading resumes
9d ago
EOLS
Premium
The Fly
Evolus announces FDA approval of Evolysse products
9d ago
EOLS
Premium
The Fly
Evolus trading halted, news pending
9d ago
EOLS
Premium
The Fly
Evolus price target raised to $22 from $20 at Barclays
26d ago
EOLS
Premium
The Fly
TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
1M ago
GM
DHI
Premium
The Fly
Evolus sees FY25 revenue $345M-$355M, consensus $347.37M
1M ago
EOLS
Premium
The Fly
Evolus expects FDA approval for Evolysse within 90 days, ahead of schedule
1M ago
EOLS
Premium
The Fly
Evolus reports preliminary Q4 revenue $79M, consensus $77.23M
1M ago
EOLS
Premium
The Fly
Evolus raises FY24 revenue view to $266.3M from $260M-$266M, consensus $264.21M
1M ago
EOLS
Premium
Company Announcements
Evolus, Inc. Reports Strong Q3 2024 Growth
4M ago
EOLS
Premium
The Fly
Evolus reports Q3 EPS (30c), consensus (10c)
4M ago
EOLS
Premium
The Fly
Evolus sees FY24 revenue $260M-$266M, consensus $266.1M
4M ago
EOLS
Premium
The Fly
Evolus says Estyme receives EU Medical Device Regulation certification
4M ago
EOLS
Premium
The Fly
Evolus rewards patient loyalty program surpasses 1M enrolled consumers
4M ago
EOLS
Premium
Market News
3 Best Stocks to Buy Now, 9/13/2024, According to Top Analysts
5M ago
DAL
AURA
Premium
The Fly
Evolus price target raised to $20 from $16 at Barclays
5M ago
EOLS
Premium
The Fly
Evolus raises FY24 revenue to $260M-$270M from $255M-$265M, consensus $262.5M
7M ago
EOLS
Premium
The Fly
Evolus reports Q2 non-GAAP operating income $1.1M vs. ($8.0M) last year
7M ago
EOLS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
